🔎 Trials Near Me

Почетна › Сквамозноклеточен карцином на глава и врат › Њујорк › New York City

Клинички испитувања за Сквамозноклеточен карцином на глава и врат во New York City, NY

39 студии за Сквамозноклеточен карцином на глава и врат бараат учесници на локации во и околу New York City (во радиус од околу 30 милји). Отворете ја студијата за да видите кој може да учествува и како да го контактирате тимот.

Официјален текст на студијата (англиски)

Барате учесници за студија? Истакнете ја на врвот од оваа страница — $99 за 30 дена →

High-dose Prophylactic Gabapentin (HOPE) vs. Placebo to Prevent Opioid Use for Oral Mucositis Pain During Concurrent Chemoradiation for Head and Neck Cancer

Се регрутираФаза 3
  • Manhattan Eye Ear and Throat Hospital, New York
  • Lenox Hill Hospital, New York
Возраст 18 и постари · Сите полови · Ажурирано 2.10.2026 · NCT06992427

A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors

Се регрутираФаза 1
  • NYU Langone Medical Center - Perlmutter Cancer Center (NYU Cancer Institute), New York
  • NYU Langone Medical Center - Perlmutter Cancer Center (NYU Cancer Institute), New York
  • Icahn School of Medicine at Mount Sinai, New York
  • и уште 2
Возраст 18 и постари · Сите полови · Ажурирано 2.10.2026 · NCT06465069

FORTIFI-HN01: A Study of Ficerafusp Alfa (BCA101) or Placebo in Combination With Pembrolizumab in First-Line PD-L1-pos, R or M HNSCC

Се регрутираФаза 2/3
  • Site #0155, New York
  • Site#0142, New York
Возраст 18 и постари · Сите полови · Ажурирано 2.10.2026 · NCT06788990

Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors

Се регрутираФаза 1
  • Exelixis Clinical Site #60, New York
  • Exelixis Clinical Site #6, New York
Возраст 18 и постари · Сите полови · Ажурирано 1.10.2026 · NCT05176483

Testing the Addition of Anti-Cancer Drug, Cetuximab, to Standard of Care Treatment (Pembrolizumab) for Returning or Spreading Head and Neck Cancer After Previous Treatment

Се регрутираФаза 3
  • Memorial Sloan Kettering Cancer Center, New York
Возраст 18 и постари · Сите полови · Ажурирано 1.10.2026 · NCT06589804

A Study of NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation

Се регрутираФаза 1
  • Research Site, New York
Возраст 18 и постари · Сите полови · Ажурирано 29.9.2026 · NCT05877599

A Study of Amivantamab in Addition to Standard of Care Agents (SOC) Compared With SOC Alone in Participants With Recurrent/Metastatic Head and Neck Cancer

Се регрутираФаза 3
  • Laura and Isaac Perlmutter Cancer Center at NYU Langone Health, New York
Возраст 18 и постари · Сите полови · Ажурирано 25.9.2026 · NCT07276399

BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study

Се регрутираФаза 2
  • Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York
Возраст 18 и постари · Сите полови · Ажурирано 25.9.2026 · NCT05136196

Testing What Happens When an Immunotherapy Drug (Pembrolizumab) is Given by Itself Compared to the Usual Treatment of Chemotherapy With Radiation After Surgery for Recurrent Head and Neck Squamous Cell Carcinoma

Се регрутираФаза 2
  • Mount Sinai Union Square, New York
  • Mount Sinai Chelsea, New York
  • Mount Sinai Hospital, New York
  • и уште 1
Возраст од 18 до 79 · Сите полови · Ажурирано 22.9.2026 · NCT04671667

Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors

Се регрутираФаза 1
  • Memorial Sloan Kettering Cancer Center Head Neck Services, New York
Возраст 18 и постари · Сите полови · Ажурирано 21.9.2026 · NCT05983432

Candida Therapeutic Vaccine in Head and Neck Cancer Patients to Reduce Recurrence

Се регрутираФаза 2
  • Perlmutter Cancer Center at NYU Langone Health, New York
Возраст од 18 до 100 · Сите полови · Ажурирано 15.9.2026 · NCT05952934

Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery

Се регрутираФаза 2
  • Manhattan Eye Ear and Throat Hospital, New York
  • Lenox Hill Hospital, New York
Возраст 18 и постари · Сите полови · Ажурирано 14.9.2026 · NCT02734537

Study of Volrustomig as Monotherapy or in Combination With Anti- Cancer Agents in Participants With Advanced/Metastatic Solid Tumors

Се регрутираФаза 2
  • Research Site, New York
Возраст 18 и постари · Сите полови · Ажурирано 11.9.2026 · NCT06535607

First in Human Study of TUB-030 in Patients With Advanced Solid Tumors

Се регрутираФаза 1/2
  • Mount Sinai, New York
Возраст 18 и постари · Сите полови · Ажурирано 11.9.2026 · NCT06657222

ADCE-T02, a Tissue Factor Targeted Antibody-Drug Conjugate, in Patients With Selected Advanced Solid Tumours

Се регрутираФаза 1
  • Memorial Sloan Kettering Cancer Center, New York
Возраст 18 и постари · Сите полови · Ажурирано 9.9.2026 · NCT06597721

A Longitudinal Multi-Omic Biomarker Profiling Study of Patients With Head & Neck Squamous Cell Carcinoma (HNSCC)

Се регрутираНабљудувачка студија
  • Mount Sinai Hospital, New York
Возраст 18 и постари · Сите полови · Ажурирано 3.9.2026 · NCT06163534

Comparing Sentinel Lymph Node (SLN) Biopsy With Standard Neck Dissection for Patients With Early-Stage Oral Cavity Cancer

Се регрутираФаза 2/3
  • Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York
  • Memorial Sloan Kettering Cancer Center, New York
Возраст 18 и постари · Сите полови · Ажурирано 17.8.2026 · NCT04333537

Study to Assess GTAEXS617 in Participants With Advanced Solid Tumors

Се регрутираФаза 1/2
  • Memorial Sloan Kettering Cancer Center, New York
Возраст 18 и постари · Сите полови · Ажурирано 13.8.2026 · NCT05985655

A Study of Decreasing Radiation Therapy and Chemotherapy in People With Head and Neck Cancer

Се регрутираФаза 2
  • Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
Возраст 18 и постари · Сите полови · Ажурирано 12.8.2026 · NCT05544136

A Study of MQ710 With and Without Pembrolizumab in People With Solid Tumor Cancer

Се регрутираФаза 1
  • Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
Возраст 18 и постари · Сите полови · Ажурирано 12.8.2026 · NCT05859074

A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)

Се регрутираФаза 1/2
  • NYU Langone Health, New York
  • Icahn School of Medicine At Mount Sinai Prime, New York
Возраст 18 и постари · Сите полови · Ажурирано 5.8.2026 · NCT06330064

A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid Tumors

Се регрутираФаза 1/2
  • Mt. Sinai, New York
  • Memorial Sloan Kettering Cancer Center, New York
Возраст 18 и постари · Сите полови · Ажурирано 29.7.2026 · NCT03526835

The Sinai Robotic Surgery Trial in HPV-related Oropharyngeal Squamous Cell Carcinoma (SIRS 2.0 Trial)

Се регрутираФаза 2
  • Mount Sinai Health System, New York
Возраст 18 и постари · Сите полови · Ажурирано 22.7.2026 · NCT05419089

A Study of Cemiplimab With Chemotherapy and Immunotherapy in People With Head and Neck Cancer

Се регрутираФаза 1
  • Memorial Sloan Kettering Cancer Center, New York
Возраст 18 и постари · Сите полови · Ажурирано 21.7.2026 · NCT04722523

First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors

Се регрутираФаза 1/2
  • Memorial Sloan Kettering Cancer Center, New York
Возраст 18 и постари · Сите полови · Ажурирано 7.7.2026 · NCT05768139

A Study of Sigvotatug Vedotin in Advanced Solid Tumors

Се регрутираФаза 1
  • North Shore Hematology Oncology Associates P.C. DBA New York Cancer and Blood Specialists, New York
  • Columbia University Irving Medical Center, New York
Возраст 18 и постари · Сите полови · Ажурирано 6.7.2026 · NCT04389632

Study With ABBV-CLS-484 in Participants With Locally Advanced or Metastatic Tumors

Се регрутираФаза 1
  • NYU Laura and Isaac Perlmutter Cancer Center - 34th Street /ID# 257869, New York
Возраст 18 и постари · Сите полови · Ажурирано 4.6.2026 · NCT04777994

A Study of the Use of Fat Flap Reconstruction to Reduce Neck Injury After Cancer Treatment

Се регрутира
  • Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
Возраст 18 и постари · Сите полови · Ажурирано 3.6.2026 · NCT05889091

A Study of Radiation Therapy After Surgery in People With Oral Tongue Squamous Cell Carcinoma

Се регрутираФаза 2
  • Memorial Sloan Kettering Cancer Center, New York
Возраст 18 и постари · Сите полови · Ажурирано 29.5.2026 · NCT06485778

DB-1311 in Combination With BNT327 or DB-1305 in Advanced/Metastatic Solid Tumors

Се регрутираФаза 2
  • USA04-0, New York
Возраст 18 и постари · Сите полови · Ажурирано 22.5.2026 · NCT06953089

A Study of Ficlatuzumab in Combination With Cetuximab in Participants With Recurrent or Metastatic (R/M) HPV Negative Head and Neck Squamous Cell Carcinoma

Се регрутираФаза 3
  • Manhattan Eye, Ear & Throat Hospital, New York
Возраст 18 и постари · Сите полови · Ажурирано 9.4.2026 · NCT06064877

A Study of Sacituzumab Govitecan in Combination With Cetuximab in People With Head and Neck Squamous Cell Cancer (HNSCC)

Се регрутираФаза 2
  • Memorial Sloan Kettering Cancer Center (All Protocol Activites), New York
Возраст 18 и постари · Сите полови · Ажурирано 19.2.2026 · NCT07063212

A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation

Се регрутираФаза 1
  • NYU Langone Health, New York
  • Memorial Sloan Kettering Cancer Center, New York
Возраст 18 и постари · Сите полови · Ажурирано 13.2.2026 · NCT06778863

VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma

Се регрутираФаза 1/2
  • Weill Cornell Medicine, Cornell University (site 126), New York
Возраст од 18 до 80 · Сите полови · Ажурирано 11.12.2025 · NCT03556228

A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors

Се регрутираФаза 1/2
  • Research Site 107, New York
Возраст 18 и постари · Сите полови · Ажурирано 21.11.2025 · NCT05914116

A Phase I/II Study of VLS-1488 in Subjects With Advanced Cancer

Се регрутираФаза 1/2
  • Memorial Sloan Kettering Cancer Center, New York
Возраст 18 и постари · Сите полови · Ажурирано 4.11.2025 · NCT05902988

A Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumors That Express EGFR and Have Lost HLA-A*02 Expression

Се регрутираФаза 1/2
  • NYU Langone Health, New York
Возраст 18 и постари · Сите полови · Ажурирано 9.9.2025 · NCT06682793

Study of Safety and Tolerability of BCA101 Monotherapy and in Combination Therapy in Patients With EGFR-driven Advanced Solid Tumors

Се регрутираФаза 1
  • Memorial Sloan Kettering, New York
  • Columbia University Herbert Irving Comprehensive Cancer Center, New York
Возраст 18 и постари · Сите полови · Ажурирано 15.8.2025 · NCT04429542

Detection of Oral and Throat Cancers Using OralViome Cancer Testing System

Се регрутираНабљудувачка студијаДобредојдени се здрави волонтери
  • NYMC, New York
Возраст 18 и постари · Сите полови · Ажурирано 29.1.2025 · NCT05451303

Испитувања за Сквамозноклеточен карцином на глава и врат во други градови

Други студии во New York City

Од ClinicalTrials.gov, податоци преземени 6.10.2026. Секоја студија ги поставува своите услови за вклучување; тимот на студијата одлучува кој може да учествува.